From Yahoo News:
Monday January 26, 11:53 am Eastern Time
Company Press Release
SOURCE: Carrington Laboratories, Inc.
Carrington Laboratories Estimates Profitable Year-End Results
IRVING, Texas, Jan. 26 /PRNewswire/ -- Carrington Laboratories, Inc., (Nasdaq: CARN - news) announced that it is
estimating a fourth quarter profit and that the net profit for the year l997 will be about $200,000, or $.02 per share, compared
to a reported loss of $5,523,000, or ($.74) per share, for 1996. A Company spokesperson noted that with the anticipated
results, Carrington will have reported profits for four of the past five quarters.
The spokesperson added that the Company's focus on its consumer business resulted in over a forty percent increase in
revenues for the year from consumer products and raw materials. Additionally, for the first time since 1994, the Company
expects to record an increase in annual sales of its growing line of wound care products.
All estimated results are subject to the completion of the annual audit of the Company's financial statements currently underway.
Carlton E. Turner, Carrington president and CEO remarked, ''We are gratified to see the favorable results of our efforts,
begun in late 1995, to turn our operations around.''
Carrington Laboratories, Inc., is an emerging research-based pharmaceutical and medical device company engaged in
developing naturally- occurring, complex carbohydrates, other nature-based therapeutics and oral technology products; and in
manufacturing and marketing products for the management of wounds and for consumer products made from
naturally-occurring Aloe vera L. Carrington currently markets more than 70 application-specific products.
SOURCE: Carrington Laboratories, Inc.
|
